RNL Bio Company Limited (003190) Company Profile - CorporateInformation.com

Company Search:

Advanced Search

Wright Investors Service Perspectives


	The Wright Reports site is no longer hosted or operated by Manta. Please review the following: 1. You have been redirected to CorporateInformation.com where you can view Snapshot reports or purchase Wright reports or subscriptions of your choosing. 2. If you were previously linking to Wright Reports please change your links to www.corporateinformation.com 3. If you are a paid subscriber with an active subscription please continue on to the member site: http://member.corporateinformation.com/home.asp 4. For additional information related to CorporateInformation.com please contact help@corporateinformation.com, Contact phone nr to be provided later)

RNL Bio Company Limited Company Snapshot

Business Description:

RNL Bio Company Limited operates in the Commercial physical research sector. RNL BIO Co., Ltd. is engaged in the manufacturing of cell therapy products. The Company provides three categories of products: stem cells, which include lipostem-femoran remedies for hip joint fractures, lipostem-DM remedies for diabetes mellitus, astrostem remedies for spinal cord injuries, vascostem remedies for ischemic cardiac cerebral infarctions, cancerstem remedies for cancers and serum free mediums for stem cell proliferations, as well as stem cell cosmetics; endocrine remedies, including antidiabetic mellitus, growth promotion and diet products, and bio safety products such as anti-bacterial disinfectants. The Company is also engaged in animal medicine and fashion business. It acquired additional shares of RNLNATURALLIFE.CO.,LTD, raising its stake in the latter to 63.30%, on May 30, 2011. On December 16, 2011, the Company completed the spin-off of its fashion, animal medicine and investment businesses into there newly established wholly owned subsidiaries. In our complete report available for purchase the company is compared to: Inktec Co., Ltd., Samseong Publishing Co Ltd and Goldis Berhad.

RNL Bio Company Limited

Stock Performance Chart for RNL Bio Company Limited

Stock Data:

Recent Stock Performance:

Current Price (2/3/2012): 5,520.00
(Figures in Korean Won)

1 Week	-1.4%		13 Weeks	7.0%

4 Weeks	-25.8%		52 Weeks	170.6%

RNL Bio Company Limited Key Data:

	Ticker:	003190	Country:	KOREA (SOUTH)

	Exchanges:	SEO	Major Industry:	Paper

			Sub Industry:	Printing & Writing Paper

	2010 Sales	76,486,749,000 (Year Ending Jan 2011).	Employees:	152

	Currency:	Korean Won	Market Cap:	463,874,889,120

	Fiscal Yr Ends:	December	Shares Outstanding:	84,035,306

	Share Type:	Common	Closely Held Shares:	10,291,329

Feedback | Terms and Conditions | Privacy Policy | Site Index

CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.